A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes

Hae Kyung Yang, Kyung Wan Min, Sung Woo Park, Choon Hee Chung, Kyong Soo Park, Sung Hee Choi, Ki Ho Song, Doo Man Kim, Moon Kyu Lee, Yeon Ah Sung, Sei Hyun Baik, In Joo Kim, Bong Soo Cha, Jeong Hyun Park, Yu Bae Ahn, In Kyu Lee, Soon Jib Yoo, Jaetaek Kim, Ie Byung Park, Tae Sun ParkKun Ho Yoon

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science